Literature DB >> 32748769

Ferritin, Erythrocyte Sedimentation Rate, and C-Reactive Protein Level in Patients with Chikungunya-Induced Chronic Polyarthritis.

Maira Sant Anna Genaro1,2, Micheli Said de Marchi2, Matheus Yung Perin2, Isabelle Silva Cossô2, Renata Dezengrini Slhessarenko1.   

Abstract

Chikungunya virus (CHIKV) is a global emergent arthritogenic alphavirus transmitted by anthropophilic Stegomyia mosquitoes. Chikungunya fever may evolve to chronic arthralgia in 57-80% of infected patients. This study was developed to identify possibly fast, simple low-cost biomarkers to monitor chronic CHIKV-induced articular disease. Between 2017 and 2018, we analyzed clinical data of patients meeting the criteria established by standard protocols to define chronic chikungunya articular disease. Patients were classified according to the disease activity scores, inflammatory biomarkers (erythrocyte sedimentation rate [ESR], ferritin, and C-reactive protein [CRP] serum), positive rheumatoid factor, comorbidities, smoking, and previous use of corticosteroids determined before beginning therapy. Of 106 patients, 98 (92.5%) were women with mean age of 52 ± 13 years, 6.8 ± 4.4 months of illness duration at the first medical appointment, and 6.7 ± 4.5 affected joints. Mean ESR (26 ± 19), CRP (2.6 ± 3.6), and stratified ferritin (144 ± 115) levels were normal according to reference values. There was no significance in comparing the levels of inflammatory biomarkers and the additional variables analyzed in the presence of moderate chronic joint disease in the study population. However, we identified a negative correlation between disease activity measures and duration of disease at the first medical evaluation after initial infection (P < 0.001), corroborating data observed in the literature.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32748769      PMCID: PMC7646772          DOI: 10.4269/ajtmh.20-0066

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

1.  Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study).

Authors:  Eric Bouquillard; Adrian Fianu; Marianne Bangil; Nathalie Charlette; Anne Ribéra; Alain Michault; François Favier; Fabrice Simon; René-Marc Flipo
Journal:  Joint Bone Spine       Date:  2017-02-24       Impact factor: 4.929

Review 2.  Chikungunya virus and autoimmunity.

Authors:  Amir Tanay
Journal:  Curr Opin Rheumatol       Date:  2017-07       Impact factor: 5.006

Review 3.  Chikungunya Infection: a Global Public Health Menace.

Authors:  A J Mathew; A Ganapati; J Kabeerdoss; A Nair; N Gupta; P Chebbi; S K Mandal; Debashish Danda
Journal:  Curr Allergy Asthma Rep       Date:  2017-02       Impact factor: 4.806

4.  Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?

Authors:  Helena Enocsson; Christopher Sjöwall; Thomas Skogh; Maija-Leena Eloranta; Lars Rönnblom; Jonas Wetterö
Journal:  Arthritis Rheum       Date:  2009-12

5.  Chikungunya virus infection. A retrospective study of 107 cases.

Authors:  S W Brighton; O W Prozesky; A L de la Harpe
Journal:  S Afr Med J       Date:  1983-02-26

6.  Chikungunya chronic disease: a systematic review and meta-analysis.

Authors:  Enny S Paixão; Laura C Rodrigues; Maria da Conceição N Costa; Martha Itaparica; Florisneide Barreto; Patrick Gérardin; Maria Glória Teixeira
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-07-01       Impact factor: 2.184

7.  Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases.

Authors:  Fabrice Simon; Philippe Parola; Marc Grandadam; Sabrina Fourcade; Manuela Oliver; Philippe Brouqui; Pierre Hance; Philippe Kraemer; Anzime Ali Mohamed; Xavier de Lamballerie; Rémi Charrel; Hugues Tolou
Journal:  Medicine (Baltimore)       Date:  2007-05       Impact factor: 1.889

8.  Emergence and potential for spread of Chikungunya virus in Brazil.

Authors:  Marcio Roberto Teixeira Nunes; Nuno Rodrigues Faria; Janaina Mota de Vasconcelos; Nick Golding; Moritz U G Kraemer; Layanna Freitas de Oliveira; Raimunda do Socorro da Silva Azevedo; Daisy Elaine Andrade da Silva; Eliana Vieira Pinto da Silva; Sandro Patroca da Silva; Valéria Lima Carvalho; Giovanini Evelim Coelho; Ana Cecília Ribeiro Cruz; Sueli Guerreiro Rodrigues; Joao Lídio da Silva Gonçalves Vianez; Bruno Tardelli Diniz Nunes; Jedson Ferreira Cardoso; Robert B Tesh; Simon I Hay; Oliver G Pybus; Pedro Fernando da Costa Vasconcelos
Journal:  BMC Med       Date:  2015-04-30       Impact factor: 8.775

Review 9.  Prevalence of chronic comorbidities in chikungunya: A systematic review and meta-analysis.

Authors:  Alaa Badawi; Seung Gwan Ryoo; Denitsa Vasileva; Sahar Yaghoubi
Journal:  Int J Infect Dis       Date:  2017-12-20       Impact factor: 3.623

10.  Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.

Authors:  Daouda Sissoko; Denis Malvy; Khaled Ezzedine; Philippe Renault; Frederic Moscetti; Martine Ledrans; Vincent Pierre
Journal:  PLoS Negl Trop Dis       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.